title: Neuropathic pain in cancer patients: A brief review.
abstract: Neuropathic pain (NP) is initiated or caused by a primary lesion or dysfunction in the nervous system. The NP in cancer patients is typically due to a combination of inflammatory, neuropathic, ischemic, infiltrative, and compression mechanisms that involve one or more anatomic sites. These patients will often have various types of co-existing pain syndromes and co-morbidities. Thus, any treatment plan needs to be individualized. After a thorough clinical assessment and evaluation, a combination therapy including anticonvulsants, antidepressants, N-methyl-D-aspartate antagonists, opiates, topical agents, and interventional procedures should be considered in these patients.
authors.affiliation: Department of Anesthesiology and Pain Medicine, Henry Ford Hospital, Detroit, USA.
authors.forename: V
authors.initials: V
authors.lastname: Loomba
authors.forename: H
authors.initials: H
authors.lastname: Kaveeshvar
authors.forename: A
authors.initials: A
authors.lastname: Upadhyay
authors.forename: N
authors.initials: N
authors.lastname: Sibai
mesh_terms: D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009437:Neuralgia / Q000209:etiology*